Brief: Nanexa 30 Mg Nex-22 Shows 36-Day Exposure Without Significant GI Side Effects
24/06/2025 07:06
June 24 (Reuters) - Nanexa AB NANEXA.ST: PRESENTS ONCE-MONTHLY LIRAGLUTIDE STUDY AT ADA SCIENTIFIC SESSIONS 30 MG NEX-22 SHOWS 36-DAY EXPOSURE WITHOUT SIGNIFICANT GI SIDE EFFECTS Source text: ID:nMFN6FDskJ Further company coverage: NANEXA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))